Cite

HARVARD Citation

    Nagai, H. et al. (2017). Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma. Leukemia & lymphoma. 58 (12), pp. 2845-2851. [Online]. 
  
Back to record